Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Undocumented migrant children in Denmark present with diverse health needs and sometimes have critical health conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Children with dyskinetic cerebral palsy are severely affected as compared to bilateral spastic cerebral palsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Parental views on the principles for cluster randomised trials involving neonates and infants

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Structural brain maturation differs between preterm and term piglets, whereas brain activity does not

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Low-saturated-fat and low-cholesterol diet does not alter pubertal development and hormonal status in adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Sertraline in primary care: comments on the PANDA trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Beta-blockers for suspected or diagnosed acute myocardial infarction

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age.

METHODS: In 2012-2013 the phase II randomised Safeguarding the Brains of our Smallest Children trial compared visible cerebral near infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition and the parental Ages and Stages Questionnaire, (ASQ).

RESULTS: There were no respective differences between the intervention (n=65) and control (n=50) groups with regard to the mean mental developmental index (89.6 ±19.5 versus 88.4 ±14.7, p=0.77), ASQ score (215 ±58 versus 213 ±58, p=0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p=0.58).

CONCLUSIONS: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalActa paediatrica
Volume108
Issue number2
Pages (from-to)275-281
ISSN1651-2227
DOIs
Publication statusPublished - 2019

ID: 54639653